Syphilis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Key Companies – Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc, Danaher Corporation

The Syphilis market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Syphilis pipeline products will significantly revolutionize the Syphilis market dynamics.

DelveInsight’s “Syphilis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Syphilis, historical and forecasted epidemiology as well as the Syphilis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Syphilis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

To Know in detail about the Syphilis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Syphilis Market Insights

Syphilis Overview
Syphilis is a sexually transmitted disease (STD) caused by the bacterium Treponema pallidum. It can cause serious health sequelae if not adequately treated. Syphilis is transmitted from person to person by direct contact with a syphilitic sore, known as a chancre. Chancres can occur on or around the external genitals, in the vagina, around the anus, or in the rectum, or in or around the mouth. Transmission of syphilis can occur during vaginal, anal, or oral sex. In addition, pregnant women with syphilis can transmit the infection to their unborn child.

Some of the key facts of the Syphilis Market Report:
• The Syphilis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• Syphilis is a sexually-transmitted infection caused by the bacteria, Treponema pallidium. It is most infectious in the first two stages
• As per Spicknall et al., in the US there were an estimated 156,000 (Q1, 132,000; Q3, 184,000) prevalent and 146,000 (Q1, 126,000; Q3, 170,000) incident syphilitic infections in people aged 14 to 49 years
• According to the World Health Organization (WHO), there were an estimated 36 million cases of syphilis in 2013 globally, with over 11 million new cases occurring annually.
• Key Syphilis Companies: Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc, Danaher Corporation, DiaSorin Group, F. Hoffmann-La Roche AG, Quidel Corporation, Siemens AG and Shenzhen New Industries Biomedical Engineering Co., Ltd., and others
• Key Syphilis Therapies: Penicillin G potassium, Ceftriaxone sodium, BPG, Doxycycline, and others
• The Syphilis epidemiology based on gender analyzed that rates of P&S syphilis have increased among men, and is likely attributable to an increase in cases among MSM

Get a Free sample for the Syphilis Market Report

Key benefits of the Syphilis Market report:
1. Syphilis market report covers a descriptive overview and comprehensive insight of the Syphilis Epidemiology and Syphilis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. The Syphilis market report provides insights on the current and emerging therapies.
3. Syphilis market report provides a global historical and forecasted market covering drug outreach in 7MM.
4. The Syphilis market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Syphilis market.

Download the report to understand which factors are driving Syphilis epidemiology trends @ Syphilis Epidemiological Insights

Syphilis Market
The dynamics of the Syphilis market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.
“The implementation of screening program and increase in awareness about sex, lead to syphilis testing market growth. Hence, prevention and control of transmission of STDs remain of vital importance and of utmost priority across all regions. Such prevention and control of transmission of syphilis can be possible by early detection diagnostic testing.”

Syphilis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Syphilis Epidemiology Segmentation:
The Syphilis market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
• Total Prevalence of Syphilis
• Prevalent Cases of Syphilis by severity
• Gender-specific Prevalence of Syphilis
• Diagnosed Cases of Episodic and Chronic Syphilis

Syphilis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Syphilis market or expected to get launched during the study period. The analysis covers Syphilis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Syphilis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Discover more about therapies set to grab major Syphilis market share @ Syphilis market forecast

Scope of the Syphilis Market Report
• Study Period: 2019–2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Syphilis Companies: Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc, Danaher Corporation, DiaSorin Group, F.
Hoffmann-La Roche AG, Quidel Corporation, Siemens AG and Shenzhen New Industries Biomedical Engineering Co., Ltd., and others
• Key Syphilis Therapies: Penicillin G potassium, Ceftriaxone sodium, BPG, Doxycycline, and others
• Syphilis Therapeutic Assessment: Syphilis current marketed and Syphilis emerging therapies
• Syphilis Market Dynamics: Syphilis market drivers and Syphilis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
• Syphilis Unmet Needs, KOL’s views, Analyst’s views, Syphilis Market Access and Reimbursement

Table of Contents
1. Syphilis Market Report Introduction
2. Executive Summary for Syphilis
3. SWOT analysis of Syphilis
4. Syphilis Patient Share (%) Overview at a Glance
5. Syphilis Market Overview at a Glance
6. Syphilis Disease Background and Overview
7. Syphilis Epidemiology and Patient Population
8. Country-Specific Patient Population of Syphilis
9. Syphilis Current Treatment and Medical Practices
10. Syphilis Unmet Needs
11. Syphilis Emerging Therapies
12. Syphilis Market Outlook
13. Country-Wise Syphilis Market Analysis (2019–2032)
14. Syphilis Market Access and Reimbursement of Therapies
15. Syphilis Market Drivers
16. Syphilis Market Barriers
17. Syphilis Appendix
18. Syphilis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

To know more about Syphilis treatment, visit @ Syphilis Medications

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting